Oncology & Cancer

Study validates therapy for aggressive bladder cancer

Findings from a new study led by Yale Cancer Center researchers show enfortumab vedotin is effective in patients with muscle-invasive bladder cancer (MIBC) not eligible for cisplatin chemotherapy. The data is from Cohort ...

Medical economics

Little test, big impact: Dipstick screening for hematuria

As the saying goes, "the sooner the better," and such is the case for the detection of kidney and urological diseases. Early detection is key, and may be achieved through the use of a dipstick urine test. Recently, researchers ...

Oncology & Cancer

New method to model bladder cancer treatments

Bladder cancer presents a number of challenges when choosing a course of treatment, but researchers at Iowa State University hope their innovative research might help doctors and patients arrive at an optimal treatment plan ...

Oncology & Cancer

Study tackles reducing bladder cancer recurrence

National and international guidelinesĀ call forĀ administration of postoperative immediate chemotherapy to reduce recurrence of non-muscle invasive bladder cancer. Yet this is done in less than half of cases. A new study ...

page 10 from 40